About DoseMe
DoseMe is a company based in Houston (United States) founded in 2014 by Robert McLeay was acquired by Fairlong Capital in January 2023. DoseMe offers products and services including DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations. DoseMe operates in a competitive market with competitors including Ivenix, Hygieia, Assurex Health, InsightRx and GenXys, among others.
- Headquarter Houston, United States
- Founders Robert McLeay
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Doseme Pty Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
AnewHealth
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DoseMe
DoseMe offers a comprehensive portfolio of products and services, including DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations.
Bayesian tool for accurate drug dosing and patient outcome optimization
Specialized calculator for precise vancomycin dose adjustments
Web-based tools for data analysis and system integration in healthcare
People of DoseMe
Unlock access to complete
Funding Insights of DoseMe
Detailed funding history for DoseMe
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DoseMe
DoseMe has secured backing from 2 investors. Prominent investors backing the company include AnewHealth and Fairlong Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cloud-based medication risk optimization solutions are provided for healthcare organizations.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for DoseMe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DoseMe
Investment portfolio details for DoseMe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DoseMe
Detailed financials for DoseMe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Doseme Comparisons
Peer comparison for DoseMe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DoseMe
DoseMe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ivenix, Hygieia, Assurex Health, InsightRx and GenXys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Infusion management systems are developed with wireless web-based architecture.
|
|
| Locked | Locked | Locked |
Insulin dosage guidance for diabetes is provided via handheld devices.
|
|
| Locked | Locked | Locked |
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
|
|
| Locked | Locked | Locked |
Precision dosing is optimized via machine learning and patient data.
|
|
| Locked | Locked | Locked |
Provider of pharmacogenetic testing and a medication decision support system
|
|
| Locked | Locked | Locked |
Personalized supplement recommendations are generated from genomic and health data.
|
Detailed competitors of DoseMe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Doseme
Complete news archive for DoseMe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DoseMe
DoseMe was founded in 2014.
DoseMe is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Charles Cornish is the current CEO of DoseMe.
DoseMe was founded in 2014 in Houston, United States, within the precision medicine sector. A platform is offered to doctors, enabling real-time pharmacokinetic measurements via electronic health records. Drug doses are calculated and compared, with customizations made for individual patients. HIPAA compliance is maintained, and integration with EHR systems is supported to aid drug optimization.
DoseMe's top competitors include Assurex Health, Ivenix and Hygieia.
DoseMe offers DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations.
DoseMe has 2 investors. Key investors include AnewHealth, and Fairlong Capital.